Pinsent Masons and Eversheds Sutherland lead on Chelsea stadium fight

Pinsent Masons and Eversheds Sutherland are taking the lead in a ‘right to light’ dispute over Chelsea FC’s new £1bn stadium, The Lawyer understands.

Premium content

This article is only available to Premium subscribers of The Lawyer. Premium subscribers benefit from accessing all of our award-winning online content including interviews, commentary, analysis and in-depth research.

View our subscription options

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here 

Latest Briefings

FCA opens notifications for temporary permissions regime in case of no-deal Brexit

By François Pfister, Anne-Gaëlle Delabye In order to ensure that investment funds that are currently marketed in the United Kingdom under the European Economic Area (EEA) passporting regime continue to be able to do so in the event of there being no implementation period based on the withdrawal agreement after 29 March (no-deal Brexit), the […]

Changes in the procedure for admission of foreign medical devices and medicines to public procurement in Russia

On 1 January 2019, amendments to the Resolution of the Government of the Russian Federation No. 102 of 05.02.2015 that provides for restrictions and conditions for the admission of certain types of medical devices originating from foreign countries for the purpose of procurement for state and municipal needs (“Resolution No. 102”). And the Resolution of […]

FIRM FACTS

PINSENT MASONS LLP


RANKINGS

UK 200: 14

REVENUE

£423M

PARTNERS

398

LAWYERS

1470

OFFICES

30

VIEW MORE

CLIENTS (134)
MATTERS (469)
MANAGEMENT TEAM (107)

Recommended

Vischer advises Oculis on CHF20m financing round

Oculis, a clinical-stage biotechnology company focused on the development of non-invasive topical treatment for back-of-the-eye diseases, announced the completion of a CHF 20m Series B financing. The round involved a syndicate of leading transatlantic life sciences investors composed of Novartis Venture Fund, Pivotal bioVenture Partners and Bay City Capital as well as existing investors including […]

Webinar 16 January 2018 | 2pm: Building better relationships with your CRM

Cracking the user adoption challenge is the first step to harnessing the power of your CRM system.  If the system is being used properly, what exactly can users expect to gain which will help them manage their relationships?  That is, after all, what CRM systems are supposed to be all about.  Is it possible to […]

Dublin, Ireland

Dechert launches training contracts in Dublin

Dechert has begun offering training contracts in its Dublin office, as the US firm eyes growth opportunities in the Irish market. Dechert launched training contracts in its Dublin office in the second half of 2017 by taking on two local law graduates as trainees. It is understood that the US firm will offer two or […]

Recruit legal talent

Get your role in front of over 300,000 legal professionals when you advertise with The Lawyer. Our team of experts provide bespoke solutions to help solve all your recruitment challenges.

Find out more

Register now to The Lawyer to access our latest news stories, read selected briefings from key firms and gain essential careers insight to help you make the most of your current and future roles.

Contact Us: if you have any questions regarding your subscription, call us on +44 (0)20 7292 3716 or email us at customerservices@thelawyer.com

Register now

Having problems?

Contact us on +44 (0)20 7292 3716 | email: customerservices@thelawyer.com

If you are looking for our Jobs site, please click here